Stéphane De Wit, MD

CHU St-Pierre
Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Gilead (Grant/Research Support)Janssen (Grant/Research Support)Merck Sharpe & Dohme (Grant/Research Support)ViiV Healthcare (Grant/Research Support)

Presentation(s):

• LB5 - PROVENT: Phase 3 Study of Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for Pre-exposure Prophylaxis of COVID-19 in Adults

  Thursday, September 30, 2021
  6:15 PM - 6:30 PM EDT